Therefore, we hope to further objectively evaluate the clinical effectiveness of DDG through a multicentre, double-blind, randomized, controlled study and comprehensively evaluate the benefits of the intervention in patients with T2DM complicated with obesity from the aspects of blood lipids, plasma glucose, insulin resistance and a chronic inflammatory status. The gene discussed is INS; the disease is type 2 diabetes mellitus.